Mouwasat Medical (4002) Financial Ratio Screen
Track 4002 screening changes
Get an email when this stock's published screening status or underlying ratios change.
MSCI new-inclusion financial-ratio snapshot
4002 financial screening at a glance
Calculation date: 2026-08-31. Financial period used: December 2024. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.
Independent method comparison
What the available screens say
How MSCI, FTSE and S&P-style screens differThe request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.
Business activity evidence
Activity assessment in progress
The supplied classification (Medical Care Facilities) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.
Revenue segments: Not yet checked against an SEC annual filing.
Profile description reviewed: Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services and specialized centers, including eye, obesity, cardiology, diabetic, robotic, fertility, rehabilitation, long term care, stroke, and skincare center. It also provides various services comprising inpatient pharmacy services, TPN and IV medication preparation units, chemotherapy medication preparation, anti-coagulant clinic, and clinical pharmacy services. In addition, the company is involved in construction and operation of hospitals, dispensaries, and special clinics; general construction of non-residential buildings, including schools, hospitals, and hotels; demolition of buildings; purchase, sale, and division of land and real estate; off-plan sales activities; operation of colleges and university institutes; and medical operation of hospitals. Further, it wholesales medical equipment and drugs. Mouwasat Medical Services Company was founded in 1974 and is based in Dammam, the Kingdom of Saudi Arabia.
Sources to verify: Secondary company profile and classification · Issuer website
A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.
Published-ratio reproductions (not certifications)
The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| MSCI | 14.1% / 30% | 9.5% / 30% | 26.6% / 30% | 0.42% / 5% | FINANCIAL SCREEN PASSED* |
| FTSE | 14.1% / 33% | 9.5% / 33% | 26.6% / 50% | 0.42% / 5% | FINANCIAL SCREEN PASSED* |
Financial Highlights
Profitability
| Gross Margin | 41.7% | |
| Operating Margin | 28.2% | |
| Net Margin | 25.5% | |
| Return on Equity (ROE) | 22.3% | |
| Return on Assets (ROA) | 9.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1.3B |
| Free Cash Flow | $821M |
| Total Debt | $762M |
| Debt-to-Equity | 25.2 |
| Current Ratio | 1.7 |
| Total Assets | $5.4B |
Price & Trading
| Last Close | SAR 71.10 |
| 50-Day MA | SAR 67.27 |
| 200-Day MA | SAR 71.59 |
| Avg Volume | 406K |
| Beta | 0.4 |
|
52-Week Range
SAR 58.65
| |
Financial data provenance and verification
The displayed fields were imported from yfinance on 2026-03-29 for the financial period December 2024. This is a secondary data feed and can differ from amended or newly filed statements.
- Issuer website — use its investor-relations filings to verify the figures.
- Field mapping, formulas and limitations.
Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.
About Mouwasat Medical (4002)
Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services and specialized centers, including eye, obesity, cardiology, diabetic, robotic, fertility, rehabilitation, long term care, stroke, and skincare center. It also provides various services comprising inpatient pharmacy services, TPN and IV medication preparation units, chemotherapy medication preparation, anti-coagulant clinic, and clinical pharmacy services. In addition, the company is involved in construction and operation of hospitals, dispensaries, and special clinics; general construction of non-residential buildings, including schools, hospitals, and hotels; demolition of buildings; purchase, sale, and division of land and real estate; off-plan sales activities; operation of colleges and university institutes; and medical operation of hospitals. Further, it wholesales medical equipment and drugs. Mouwasat Medical Services Company was founded in 1974 and is based in Dammam, the Kingdom of Saudi Arabia.
Popular halal stock checks
Explore other frequently viewed automated stock screens and compare the available financial ratios.
Frequently Asked Questions
Is Mouwasat Medical (4002) halal to invest in?
The current automated result is Financial screen passed; activity assessment pending. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.
What is Mouwasat Medical's debt ratio?
Mouwasat Medical's debt ratio is 14.1% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.
What are Mouwasat Medical's key financial metrics?
Mouwasat Medical has a market capitalization of SAR 13990M in its listing currency, trailing P/E ratio of 18.5, and revenue of $2.9B. The company maintains a gross margin of 41.7% and a net margin of 25.5%. Return on equity stands at 22.3%.
How often is the screening data updated?
Calculation date: 2026-08-31. Financial period: December 2024. These dates are shown separately because regenerating this page does not refresh the underlying data.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.